NYQ

Product Code: NYQ

Products Classified as NYQ

3134

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/neu Gene, Breast Cancer

Total Product Life Cycle (TPLC) Devices

3134

Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/neu Gene, Breast Cancer

Pre-market Approvals for NYQ

P100027

INFORM HER2 Dual ISH DNA Probe Cocktail

VENTANA MEDICAL SYSTEMS, INC.

Global Unique Device Identification Database

• 05700572032960: Chromogenic In Situ Hybridization, Nucleic Acid Amplification, Her2/Neu Gene, Breast Cancer
• 07613336158432: Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer

Maude Adverse Events

HER2 CISH PHARMD KIT	DAKO DENMARK A/S	2016-05-23
HER2 DUAL ISH	VENTANA MEDICAL SYSTEMS, INC	2016-01-14
HER2 CISM PHARMDX KIT	DAKO DENMARK A/S	2014-01-16
HER2 CISH PHARMDX KIT	DAKO DENMARK A/S	2014-01-16
HER2 CISH PHARMDX KIT	DAKO DENMARK A/S	2014-01-16
HER2 CISH PHARMDX KIT	DAKO DENMARK A/S	2014-01-16
HER2 CISM PHARMDX KIT	DAKO DENMARK A/S	2014-01-16
HER2 CISH PHARMDX KIT	DAKO DENMARK A/S	2014-01-16
HER2 CISH PHARMDEX KIT	DAKO DENMARK A/S	2014-01-16